Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults
収録刊行物
-
- Vaccine
-
Vaccine 36 (42), 6325-6333, 2018-10
Elsevier BV